Trial Profile
Evaluation of the Safety, Efficacy, Pharmacokinetics, and Acceptability of HMR3647 20 mg/kg qd for 5 Days With Acute Otitis Media (AOM) in Children (Multicentre, Open Label, Non Comparative Study)
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 03 Apr 2008
Price :
$35
*
At a glance
- Drugs Telithromycin (Primary)
- Indications Bacterial infections; Otitis media
- Focus Therapeutic Use
- Sponsors Sanofi
- 03 Apr 2008 New trial record.